Government Asked to Expand Funding for Long-Acting HIV Prevention Drug Lenacapavir
Health advocates are pressing for expanded government funding to facilitate the broader distribution of lenacapavir, an injectable, long-acting medication crucial for HIV prevention and treatment. The urgent appeal stems from significant demand for the drug and its proven capacity to boost adherence to treatment regimens.
Despite promising initial results, several regions continue to face obstacles in accessing lenacapavir. This push for increased investment is in direct alignment with Uganda’s overarching strategy for combating HIV, which aims to significantly reduce new infections and achieve critical epidemic control milestones.
Summarized by ZZINA AI
